1 EM Balk , AH Lichtenstein , M Chung , et al. (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189, 19–30.
2 E Burillo , P Martin-Fuentes , R Mateo-Gallego , et al. (2012) Omega-3 fatty acids and HDL. How do they work in the prevention of cardiovascular disease? Curr Vasc Pharmacol 10, 432–441.
3 MC Morris , DA Evans , JL Bienias , et al. (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60, 940–946.
4 SC Cunnane , M Plourde , F Pifferi , et al. (2009) Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 48, 239–256.
5 M Fotuhi , P Mohassel & K Yaffe (2009) Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol 5, 140–152.
8 EL Schaeffer , OV Forlenza & WF Gattaz (2009) Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology (Berl) 202, 37–51.
9 C Samieri , C Feart , C Proust-Lima , et al. (2011) ω-3 Fatty acids and cognitive decline: modulation by ApoEepsilon4 allele and depression. Neurobiol Aging 32, 2317.e13–2317.e22.
10 EH Corder , AM Saunders , WJ Strittmatter , et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921–923.
11 TL Huang , PP Zandi , KL Tucker , et al. (2005) Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 65, 1409–1414.
13 LA Horrocks & YK Yeo (1999) Health benefits of docosahexaenoic acid (DHA). Pharmacol Res 40, 211–225.
14 F Calon , GP Lim , F Yang , et al. (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43, 633–645.
15 M Bouwens , O van de Rest , N Dellschaft , et al. (2009) Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 90, 415–424.
16 M Plourde & SC Cunnane (2007) Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32, 619–634.
17 C Castellano , R Chouinard-Watkins , T Brenna , et al. (2011) Does aging change docosahexaenoic acid homeostasis? Oléagineux Corps Gras Lipides (OCL) 18, 175–180.
18 SC Cunnane , R Chouinard-Watkins , CA Castellano , et al. (2013) Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: can we reconcile the evidence? Prostaglandins Leukot Essent Fatty Acids 88, 61–70.
20 PM Le , C Fraser , G Gardner , et al. (2007) Biosynthetic production of universally (13)C-labelled polyunsaturated fatty acids as reference materials for natural health product research. Anal Bioanal Chem 389, 241–249.
21 JT Brenna (1997) Use of stable isotopes to study fatty acid and lipoprotein metabolism in man. Prostaglandins Leukot Essent Fatty Acids 57, 467–472.
24 M Plourde , R Chouinard-Watkins , M Vandal , et al. (2011) Plasma incorporation, apparent retroconversion and beta-oxidation of 13C-docosahexaenoic acid in the elderly. Nutr Metab (Lond) 8, 5.
25 ZS Nasreddine , NA Phillips , V Bedirian , et al. (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53, 695–699.
26 E Freemantle , M Vandal , J Tremblay Mercier , et al. (2009) Metabolic response to a ketogenic breakfast in the healthy elderly. J Nutr Health Aging 13, 293–298.
27 U McCloy , MA Ryan , PB Pencharz , et al. (2004) A comparison of the metabolism of eighteen-carbon 13C-unsaturated fatty acids in healthy women. J Lipid Res 45, 474–485.
29 KJ Goodman & JT Brenna (1992) High sensitivity tracer detection using high-precision gas chromatography–combustion isotope ratio mass spectrometry and highly enriched [U-13C]-labeled precursors. Anal Chem 64, 1088–1095.
30 S Choquette , A Chuin , DA Lalancette , et al. (2009) Predicting energy expenditure in elders with the metabolic cost of activities. Med Sci Sports Exerc 41, 1915–1920.
31 M Emi , LL Wu , MA Robertson , et al. (1988) Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 3, 373–379.
34 C Garenc , S Aubert , J Laroche , et al. (2004) Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians. J Hum Genet 49, 691–700.
35 MJ Bullido , MJ Artiga , M Recuero , et al. (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet 18, 69–71.
36 RC Littell , PR Henry & CB Ammerman (1998) Statistical analysis of repeated measures data using SAS procedures. J Anim Sci 76, 1216–1231.
37 CR Hooijmans & AJ Kiliaan (2008) Fatty acids, lipid metabolism and Alzheimer pathology. Eur J Pharmacol 585, 176–196.
39 R Bahri , E Esteban , P Moral , et al. (2008) Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease. Lipids Health Dis 7, 46.
40 RE Gregg , LA Zech , EJ Schaefer , et al. (1986) Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78, 815–821.
41 AL Carvalho-Wells , KG Jackson , R Gill , et al. (2010) Interactions between age and apoE genotype on fasting and postprandial triglycerides levels. Atherosclerosis 212, 481–487.
42 J Kobayashi , Y Saito , K Taira , et al. (2001) Effect of apolipoprotein E3/4 phenotype on postprandial triglycerides and retinyl palmitate metabolism in plasma from hyperlipidemic subjects in Japan. Atherosclerosis 154, 539–546.
43 Y Reznik , R Morello , P Pousse , et al. (2002) The effect of age, body mass index, and fasting triglyceride level on postprandial lipemia is dependent on apolipoprotein E polymorphism in subjects with non-insulin-dependent diabetes mellitus. Metabolism 51, 1088–1092.
44 BJ Litman , SL Niu , A Polozova , et al. (2001) The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: visual transduction. J Mol Neurosci 16, 237–242, .
45 CN Serhan , CB Clish , J Brannon , et al. (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192, 1197–1204.
46 X Liang , D Zhu & H Schulz (1999) Delta3,5,7,Delta2,4,6-trienoyl-CoA isomerase, a novel enzyme that functions in the beta-oxidation of polyunsaturated fatty acids with conjugated double bonds. J Biol Chem 274, 13830–13835.
49 G Burdge (2004) Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 7, 137–144.
50 T Decsi & K Kennedy (2011) Sex-specific differences in essential fatty acid metabolism. Am J Clin Nutr 94, Suppl. 6, 1914S–1919S.
51 GC Burdge & PC Calder (2005) Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 45, 581–597.
52 GC Burdge & SA Wootton (2003) Conversion of alpha-linolenic acid to palmitic, palmitoleic, stearic and oleic acids in men and women. Prostaglandins Leukot Essent Fatty Acids 69, 283–290.
57 H Wehr , T Parnowski , S Puzynski , et al. (2000) Apolipoprotein E genotype and lipid and lipoprotein levels in dementia. Dement Geriatr Cogn Disord 11, 70–73.
58 EJ Giltay , AK van Reedt Dortland , A Nissinen , et al. (2009) Serum cholesterol, apolipoprotein E genotype and depressive symptoms in elderly European men: the FINE study. J Affect Disord 115, 471–477.